Soleno Therapeutics raises executive base salaries, grants FY2024 bonuses and equity awards

SOLENO THERAPEUTICS INC

CEO Bhatnagar base salary increased to $739,000 effective Jan 1, 2025; FY2024 cash bonus of $403,200.
CFO Mackaness base salary set at $511,000; FY2024 bonus of $193,200; 31,000 options and 14,500 RSUs awarded.
SVP Hirano base salary $432,000; FY2024 bonus $137,812; 13,800 options and 6,400 RSUs awarded.
Options vest over 4 years (monthly after 1-year cliff); RSUs vest 25% per year over 4 years.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.